Opposition · USPTO

Opposition 91292383

OtherUSPTO

Opposition 91292383 at USPTO between Forma Brands, LLC and Recure Biotechnology & Cosmetics Limited, over the mark MORPHIYA EXOMORPHIC BIOTECH THE GENESIS FORMULA, filed Jun 28, 2024. Status in the office record: other.

Status
Other
Result
Other
Filed
Jun 28, 2024
Marks involved
5
Parties

Who is involved

The parties as named in the office record.

Opponent

Forma Brands, LLC

Respondent

Recure Biotechnology & Cosmetics Limited

Timeline

How the case has moved

Dates from the USPTO record and the MORPHIYA EXOMORPHIC BIOTECH THE GENESIS FORMULA filing.

  1. MORPHIYA EXOMORPHIC BIOTECH THE GENESIS FORMULA filed

    Application 97684092 filed at the USPTO.
  2. Opposition filed

    Forma Brands, LLC started opposition 91292383 at USPTO against MORPHIYA EXOMORPHIC BIOTECH THE GENESIS FORMULA.
Marks

Marks involved

2 contested marks, 3 marks the challenger relies on.

MarkRoleApplicationOffice
MORPHIYA EXOMORPHIC BIOTECH THE GENESIS FORMULAContested97684092USPTO
MORPHIYA EXOMORPHIC BIOTECHContested97684104USPTO
MORPHERelied on85764648USPTO
MORPHERelied on86744010USPTO
MORPHERelied on88140956USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

GET /v1/proceedings/{id}
ID=prc_45a85e3b-75a3-403d-a574-aa4145a76b69
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_45a85e3b-75a3-403d-a574-aa4145a76b69",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91292383",
  "status": "other",
  "office_code": "US",
  "filed_date": "2024-06-28",
  "parties": [
    {
      "name": "Forma Brands, LLC",
      "role": "opponent"
    },
    {
      "name": "Recure Biotechnology & Cosmetics Limited",
      "role": "respondent"
    }
  ]
}